NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/04/2025
Back to search
Official data from USPTO
OLIGOMERIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OLIGOMERIX
ST13
US500000085886219Class
1, 5, 42
Filing
85886219
Registration
4760737
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
10/28/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
03/26/2013
Registration date
06/23/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/04/2025
Last transaction
10/28/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2011-08-00
First use in commerce
2011-08-00
Drawing code
4
Owner type
03
Owner location
White Plains, NY
Examiner
HOWARD,PARKER WALDRIP
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Oligomerix, Inc.
Oligomerix, Inc.
Representatives
Nicole K. McLaughlin Duane Morris LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products and compositions intended for medical researchreagentschemical entities and compounds; chemical preparations for scientific purposeschemical reagents or products for laboratory analyses for monitoringanalyzing and identifying diagnostic targets and therapeutic productsfor conducting research in connection with pharmaceutical sciences; chemical preparations intended for scientific purposesfor leading research in connection with pharmaceutical sciences
Class 5
Pharmaceutical products for the treatment of diseasesAlzheimer's disease and other neurodegenerative diseases; reagents for diagnostic purposes and diagnostic media intended for medical purposesreagents and media intended for teststests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposespharmaceutical preparations for diagnosing diseasesAlzheimer's disease and other neurodegenerative diseases; chemico-pharmaceutical preparations for diagnosingpreventing and treating diseasesAlzheimer's disease and other neurodegenerative diseases; biopharmaceutical productsreagentschemical entities and compounds for diagnosingpreventing and treating diseasesAlzheimer's disease and other neurodegenerative diseases; chemical preparations for medical and pharmaceutical purposeschemicals for diagnosing Alzheimer's disease and other neurodegenerative diseasesespecially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases
Class 42
Research and development of pharmaceutical moleculescompoundsinhibitorsantibodies and biological markers for diagnostic purposes and medicines for treating diseases; research and development of new products and preparations for the treatment of Alzheimer's disease and other neurodegenerative diseases; research and development in the field of pharmaceutical drugs; biological research; biotechnological research; technical research in the field of biotechnology; consultancy in the field of biotechnology
Publications
History of USPTO decisions and trademark events.
45 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/04/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/04/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/04/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
06/11/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/23/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/09/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/09/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/09/2022
E815
TEAS SECTION 8 & 15 RECEIVED
12/21/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/23/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/23/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/19/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/16/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/13/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/11/2015
IUAF
USE AMENDMENT FILED
04/10/2015
EISU
TEAS STATEMENT OF USE RECEIVED
04/10/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/06/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/11/2014
PUBO
PUBLISHED FOR OPPOSITION
11/11/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/22/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/03/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/11/2014
EXPI
EX PARTE APPEAL-INSTITUTED
09/11/2014
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
09/11/2014
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
09/11/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/11/2014
GNFR
FINAL REFUSAL E-MAILED
03/11/2014
CNFR
FINAL REFUSAL WRITTEN
03/11/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2014
ALIE
ASSIGNED TO LIE
02/12/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/06/2013
GNRT
NON-FINAL ACTION E-MAILED
08/06/2013
CNRT
NON-FINAL ACTION WRITTEN
08/06/2013
DOCK
ASSIGNED TO EXAMINER
07/08/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/29/2013
NWAP
NEW APPLICATION ENTERED
03/29/2013
Continuous trademark protection
Get notified about every new filing that threatens OLIGOMERIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.